The research report provides a big picture on Carrier Screening Market Growth on a global basis, offering a forecast and statistic in terms of revenue during the forecast period
Global Carrier Screening Market Research Report, by Product & Service (Services and Products), Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and others), Technology (Polymerase Chain Reaction and Microarrays), End-User (Hospitals, Reference Laboratories, Physician Offices, and Clinics and others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast till 2025
Various factors are adding to the global carrier screening market growth. As per the latest MRFR report, these factors comprise growing awareness about carrier screening, technological advances, growing emphasis on early detection & prevention, increasing number of players involved new carrier screening technology development, and new product launch.
Carrier Screening Market Regional Analysis
Based on the region, the global carrier screening market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), & the Middle East and Africa. Of these, the Americas will have the lions share in the market over the forecast period. Increasing awareness about genetic disorders & its diagnosis methods, and the huge patient population suffering from genetic diseases are adding to the global carrier screening market growth in the region.
The global carrier screening market in Europe is predicted to hold the second-largest share over the forecast period. The presence of several healthcare companies, rising focus on personalized medicine, and increasing R&D activities are adding to the global carrier screening market growth in the region.
The global carrier screening market in the APAC region is predicted to grow at a fast pace over the forecast period. Increasing awareness regarding the diagnosis techniques of genetic disorder coupled with increasing market growth is adding to the global carrier screening market growth in the region.
The global carrier screening market in the MEA is predicted to have the smallest share over the forecast period for a low per capita disposable income, especially in Africa’s underdeveloped regions, lack of awareness regarding the disease condition, and limited healthcare infrastructure.
Carrier Screening Market Key Players
Leading players profiled in the global carrier screening market report include Laboratory Corporation of America Holdings (US), Natera Inc (US), Luminex Corporation (US), Thermo Fisher Scientific Inc (US), Illumina Inc (US), Myriad Genetics (US), Sema4 (US), Quest Diagnostics Incorporated (US), Fulgent Genetics Inc (US), Opko Health (US), Invitae Corporation (US), and Eurofins Scientific (Luxembourg). Industry players have incorporated different strategies to create a niche in the market, such as acquisitions, mergers, new product launches, and more.
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.